APA

Gane E. J., Hyland R. H., Yang Y., Svarovskaia E., Stamm L. M., Brainard D. M., McHutchison J. G. & Stedman C. A. M. (20170808). Efficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2 Infection. : Gastroenterology.

Chicago

Gane Edward J, Hyland Robert H, Yang Yin, Svarovskaia Evguenia, Stamm Luisa M, Brainard Diana M, McHutchison John G and Stedman Catherine A M. 20170808. Efficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2 Infection. : Gastroenterology.

Harvard

Gane E. J., Hyland R. H., Yang Y., Svarovskaia E., Stamm L. M., Brainard D. M., McHutchison J. G. and Stedman C. A. M. (20170808). Efficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2 Infection. : Gastroenterology.

MLA

Gane Edward J, Hyland Robert H, Yang Yin, Svarovskaia Evguenia, Stamm Luisa M, Brainard Diana M, McHutchison John G and Stedman Catherine A M. Efficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2 Infection. : Gastroenterology. 20170808.